Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is facing temporary headwinds due to changes in insurance plans resulting in delays in patient census, but they are focusing on expanding their advanced practitioner capabilities and leveraging labor to improve margins. While there are setbacks in certain specialty therapies, the company continues to have strong momentum in its acute therapy business, which comes with higher gross margins. Additionally, the recent merger with BioScrip has positioned Option Care Health as a leading player in the home and alternate-site infusion market.

Bears say

Option Care Health is facing a variety of headwinds including a lowered financial guidance for 2026, a steep implied EBITDA ramp in the second half, and the expectation of difficulty in driving 21%-31% core growth without significant events such as competitive exits or procurement T/Ws. With a significant share price drop of 24%, there may be a buying opportunity for investors, but there are also company-specific risks such as potential slowdown in specialty growth and competition leading to margin pressure.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.